These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 9296958)
1. [The "antisense" strategy: a new approach in the development of antineoplastic substances and gene therapy]. Hélène C J Pharm Belg; 1997; 52(2):79-85. PubMed ID: 9296958 [No Abstract] [Full Text] [Related]
2. Automata make antisense. Condon A Nature; 2004 May; 429(6990):351-2. PubMed ID: 15164042 [No Abstract] [Full Text] [Related]
4. New approaches in cancer pharmacology: drug design and development. Report of a European School of Oncology Task Force. Eur J Cancer; 1992; 28A(6-7):1190-200. PubMed ID: 1627393 [No Abstract] [Full Text] [Related]
5. Antisense oligodeoxynucleotides as clinical therapeutic agents. Tonkinson JL; Stein CA Cancer Invest; 1996; 14(1):54-65. PubMed ID: 8597889 [No Abstract] [Full Text] [Related]
9. [Chemosensitization of hepatocellular carcinoma using antisense oligonucleotides]. Wang ZY; Lin RX; Wang SQ Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):242, 246. PubMed ID: 16635287 [No Abstract] [Full Text] [Related]
10. [Oncogenes and pharmacological approaches to cancer therapy]. Tocque B Pathol Biol (Paris); 1992 Nov; 39(9):869-70. PubMed ID: 1538914 [No Abstract] [Full Text] [Related]
11. Targeting c-myc in leukemia. Calabretta B; Skorski T Anticancer Drug Des; 1997 Jul; 12(5):373-81. PubMed ID: 9236853 [No Abstract] [Full Text] [Related]
12. [Antisense oligonucleotides: a new class of biologically active molecules]. Uteshev DB; Korostelev SA; Sergeev AV; Uteshev BS Eksp Klin Farmakol; 2004; 67(3):76-9. PubMed ID: 15341077 [TBL] [Abstract][Full Text] [Related]
13. [Antisense oligonucleotides are clinically tested. They inhibit the expression of disease-related genes]. Sommer W; Heilig M Lakartidningen; 1999 Jan; 96(4):348-54. PubMed ID: 10024826 [TBL] [Abstract][Full Text] [Related]
14. [A novel paradigm and new targets in cancer therapy]. Novik AA; Kamilova TA; Tsygan VN Vopr Onkol; 2003; 49(6):695-704. PubMed ID: 14976912 [No Abstract] [Full Text] [Related]
15. The zebrafish as a novel system for functional genomics and therapeutic development applications. Nasevicius A; Ekker SC Curr Opin Mol Ther; 2001 Jun; 3(3):224-8. PubMed ID: 11497344 [TBL] [Abstract][Full Text] [Related]
16. DNA combination therapy to stop tumor growth. Wickstrom E; Smith JB Cancer J Sci Am; 1998 May; 4 Suppl 1():S43-7. PubMed ID: 9619270 [No Abstract] [Full Text] [Related]
17. Gene therapy approaches to sensitization of human prostate carcinoma to cisplatin by adenoviral expression of p53 and by antisense jun kinase oligonucleotide methods. Gjerset R; Haghighi A; Lebedeva S; Mercola D Methods Mol Biol; 2001; 175():495-520. PubMed ID: 11462854 [No Abstract] [Full Text] [Related]